Tiffany Sy
Analyst · Lucid Capital Markets. Please go ahead
Thank you, Marc. Good morning, everyone. Yesterday, we reported second quarter normalized FFO of $20.8 million, or $0.31 per share, which is in line with our guidance and 51% higher compared to the same quarter a year ago. These results reflect lower interest expense from our debt refinancing over the past year and the rent growth that both Yael and Marc highlighted earlier. Same property NOI was $88.6 million, and same property cash basis NOI was $85.7 million, both increasing 2% year-over-year, and adjusted EBITDAre totaled $87.4 million, a 3% increase year-over-year. Turning to our balance sheet, in May, we closed a $1.62 billion 5-year interest-only mortgage loan for our consolidated joint venture at a fixed rate of 5.71%. The proceeds were used to refinance the joint venture's existing $1.4 billion floating rate loan and $205 million of fixed-rate amortizing debt. The new loan is secured by the same 90 mainland properties that collateralized the prior borrowing. As a result of this refinancing, our consolidated joint venture was able to access cash previously reserved for loan amortization and interest rate caps and distributed $38 million during the quarter, including more than $23 million to ILPT as a 61% owner. ILPT ended the quarter with cash on hand of $135 million and restricted cash of $46 million. Our net debt to total assets ratio increased to 69.2%, and our net debt leverage ratio improved to 11.5x. Turning to our outlook, for the third quarter of 2026, we expect interest expense of $61 million, including $59 million of cash interest expense and $2 million of non-cash amortization of deferred financing fees, adjusted EBITDAre between $87.5 million and $88.5 million, and normalized FFO between $0.34 and $0.36 per share. For the full year 2026, we expect capital expenditures between $29 million and $34 million and interest expense of approximately $245 million, with cash interest of $234.5 million and non-cash interest of $10.5 million. Additionally, we are increasing our Adjusted EBITDAre guidance to a range between $348 million and $353 million, a $4 million increase at the midpoint. And we are increasing normalized FFO guidance to a range of $1.31 and $1.39 per share, representing a $0.05 increase at the midpoint. In closing, ILPT is delivering attractive growth by continuing to execute on our operating and financial objectives. As we look to the back half of 2026, we are focused on building on this momentum, prudently managing our capital and creating long-term value for our shareholders. That concludes our prepared remarks. Operator, please open the line for questions.